Alpha Fusion Initiates Company-Sponsored Clinical Trial of Alpha-Emitting Radiopharmaceutical af-001 in Patients with Differentiated Thyroid Cancer
– Aiming to establish af-001 as a new therapeutic option for radioactive iodine (RAI)-naive patients with differentiated thyroid cancer – TOKYO, Oct. 31, 2025 /PRNewswire/ -- Alpha Fusion Inc. (Headquarters: Chiyoda-ku, Tokyo; CEO: Sunao Fujioka;...
Fox ESS and OSW Ink Strategic Partnership for 2GWh Energy Storage Projects at All Energy 2025
MELBOURNE, Australia, Oct. 31, 2025 /PRNewswire/ -- Fox ESS, a leading provider of renewable energy solutions, has officially announced a strategic partnership with OSW, Australia's premier solar wholesaler and distributor. The two companies have...
Alternō's Sand Battery Enters Japan: Decarbonizing Industrial Heat and Supplying Clean Heat for Greenhouse Farming
TSUKUBA, Japan, Oct. 31, 2025 /PRNewswire/ -- Alternō , an Asia-based climate-tech company pioneering sand-based thermal battery systems, announced today the establishment of Alternō Japan GK in Tsukuba City, Ibaraki Prefecture. This marks a major...
ArkBio Initiates Phase II Clinical Trial of AK0610, a Preventive Monoclonal Antibody for Respiratory Syncytial Virus Infection
SHANGHAI, Oct. 30, 2025 /PRNewswire/ -- Shanghai Ark Biopharmaceutical Co., Ltd. ("ArkBio") today announced the initiation of a Phase II clinical study of AK0610, a fully human monoclonal antibody designed to prevent respiratory syncytial virus...
WEKA Announces New NeuralMesh Architecture Built for NVIDIA BlueField-4
Revolutionary Platform Design Marks Major Evolution in AI Infrastructure, Eliminating Traditional CPU Requirements While Delivering Breakthrough Performance Density, Linear Scalability and Exceptional Power Efficiency for Enterprise AI Factories...
LUMOSA THERAPEUTICS ANNOUNCES POSITIVE RESULTS FROM LT3001(INTRAVENOUS ODATROLTIDE) PHASE 2B CLINICAL TRIAL IN ACUTE ISCHEMIC STROKE
Results presented at the 17th World Stroke Congress (WSC 2025) LT3001(Odatroltide)-202 phase 2b study met primary endpoint. No symptomatic intracranial hemorrhage occurred. Data suggest that LT3001 has the potential to provide significant clinical...
SOGAGEM Accelerates Jewelry Digitalization Through AI Trade Platform
SEOUL, South Korea, Oct. 24, 2025 /PRNewswire/ -- Korean fashion jewelry company SOGAGEM Co., Ltd. is driving the digital transformation of the Namdaemun jewelry industry through its AI-powered online trade platform. By combining artificial...
AIPro Revolutionizes Public and Industrial Safety with "AI-BOX" -- High-Precision Video Analytics Without CCTV Replacement
SEOUL, South Korea, Oct. 24, 2025 /PRNewswire/ -- AI deep learning company AIPro is drawing attention in the industrial and public safety sectors with its proprietary "AI-BOX" solution. The technology enables high-precision video analytics using...
Berlin Heals Welcomes Dr. Eric Fain as New Board Member
Berlin Heals adds MedTech Veteran Dr. Eric Fain to Board of Directors Dr. Fain brings over 35 years of strategic and start-up expertise Extensive experience in the Cardiovascular space particularly in active implants Led multiple successful...
Shimadzu Asia Pacific Celebrates 150th Anniversary -A Century and a Half of Driving Healthcare and Technological Breakthroughs
SINGAPORE, Oct. 21, 2025 /PRNewswire/ -- Shimadzu Asia Pacific joins the global celebration of Shimadzu Corporation's 150th anniversary, marking a century and a half of pioneering innovations that have shaped science, technology, and healthcare...